FRA:M5D'
s EV-to-FCF Range Over the Past 10 Years
Min: -100.14 Med: -7.8 Max: 243.92
Current: 243.92
During the past 13 years, the highest EV-to-FCF of Medical Developments International was 243.92. The lowest was -100.14. And the median was -7.80.
FRA:M5D's EV-to-FCF is ranked worse than 93.95% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.11
vs FRA:M5D: 243.92
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medical Developments International (FRA:M5D) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medical Developments International's PE Ratio (TTM) for today is calculated as:
Medical Developments International's share price for today is €0.197.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Developments International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.002.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medical Developments International EV-to-FCF Related Terms
Medical Developments International EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Developments International EV-to-FCF Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Developments International EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medical Developments International's EV-to-FCF falls into.
Medical Developments International's current Enterprise Value is €17.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Developments International's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.07 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Developments International (FRA:M5D) has a EV-to-FCF of 235.71 as of Jun. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medical Developments International and its competitors. According to the industry distribution chart, Medical Developments International ranks #528 out of 562 companies in the Drug Manufacturers industry, placing it in the top 94%.
Is Medical Developments International's EV-to-FCF too high?
Medical Developments International's current EV-to-FCF is 235.71. The Drug Manufacturers industry median EV-to-FCF is 20.11. Medical Developments International's value of 235.71 is 1072.1% above this industry median. Based on the distribution chart, Medical Developments International ranks #528 out of 562 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medical Developments International has a GF Score™ of 32/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's EV-to-FCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Medical Developments International ranks #528 out of 562 companies for EV-to-FCF. This places Medical Developments International in the lower half of its industry. The industry median EV-to-FCF is 20.11. Medical Developments International's value of 235.71 is 1072.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.11, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Developments International's current EV-to-FCF of 235.71 is 1072.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medical Developments International and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Developments International's current EV-to-FCF is 235.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (FRA:M5D) is currently considered Significantly Undervalued. The stock's GF Value™ is €0.35, compared to a current price of €0.20 — trading 43.7% below its estimated fair value. The current EV-to-FCF is 235.71 and 1072.1% above the Drug Manufacturers industry median of 20.11. Medical Developments International's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medical Developments International (FRA:M5D), the current EV-to-FCF is 235.71 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Developments International (FRA:M5D) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued.
The current stock price of €0.20 is trading 43.7% below its estimated GF Value™ of €0.35.
GuruFocus considers Medical Developments International to be Significantly Undervalued.
Key valuation signals for FRA:M5D:
EV-to-FCF: 235.71
GF Value™: €0.35 vs. price of €0.20 (43.7% below fair value)
Industry Position: 1072.1% above the Drug Manufacturers median (#528 of 562)
No single metric tells the full story. See the FRA:M5D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Developments International Business Description
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
32GF Score
Get the complete analysis for FRA:M5D
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M5D has been successfully added to your 
